- ASSISTANT CLINICAL PROFESSOR Obstetrics, Gynecology and Reproductive Science
Obstetrics & Gynecology
MD, Albert Einstein College of Medicine
Montefiore Medical Center
Fellowship, Reproductive Endocrinology & Infertility
Mount Sinai Hospital
Dr. Tanmoy Mukherjee, a board certified gynecologist and reproductive endocrinologist, is Associate Director of the Mount Sinai Division of Reproductive Endocrinology and co-director of Reproductive Medicine Associates of New York. He completed his residency at the Albert Einstein College of Medicine where he received the Leo M. Davidoff Society Award as well as the Schulman Award, and his fellowship at Mount Sinai Hospital. The author of numerous journal articles and textbook chapters, Dr. Mukherjee is also the recipient of the prestigious Society of Reproductive Surgeons Award for his outstanding research related to the effects of hydrosalpinx fluid on the outcome of in vitro fertilization.
In addition to his expertise in in vitro fertilization, egg donation and other assisted reproductive techniques, Dr. Mukherjee excels in a wide array of medical and surgical treatments for the management of endometriosis, fibroids, abnormal uterine bleeding, and abnormalities of the fallopian tubes. He has lectured and written extensively on the diagnosis and treatment of patients with recurrent spontaneous abortions. Best Doctors selected Dr. Mukherjee as one of the "Best Doctors in America" in 2005 and 2006, and Castle Connolly deemed Dr. Mukherjee as being a leader in the field in its "New York Metropolitn Area Top Doctors" in 2006. New York Magazine included Dr. Mukherjee in its 2007 and current 2008 "Best Doctors" issue and SuperDocs recently lauded him in their 2008 list. He has had numerous television appearances that include the Fox News Channel's "Healthwatch" and "Mike and Juliet Show".
Beilin Y, Bodian C, Mukherjee T, Andres L, Vincent RD, Hock DL, Sparks AE, Munson AK, Minnich ME, Steinkampf MP, Christman GM, McKay RS, Eisenkraft J. The use of propofol, nitrous oxide, or isoflurane does not affect the reproductive success rate following gamete intrafallopian transfer (GIFT): a mul. Anesthesiology 1999 Jan; 90(1): 36-41.BACKGROUND: Whether anesthetic agents administered during gamete intrafallopian transfer (GIFT) affect reproductive outcome is controversial. This multicenter pilot trial and survey had two purposes: to evaluate the effect of propofol, nitrous oxide, midazolam, and isoflurane on pregnancy outcome after GIFT, and to determine if a larger prospective, randomized study is warranted. METHODS: A written invitation was mailed to all 50 fertility programs in the United States that are members of the Society for Assisted Reproductive Technology and perform more than 30 GIFT procedures per year. They were invited to contribute information from the medical records of women who underwent GIFT during the calendar years 1993 and 1994. They were asked to document whether propofol, nitrous oxide, midazolam, a potent inhaled anesthetic agent was used during the GIFT procedure; if the woman became pregnant; and if she delivered at least one live neonate. RESULTS: Seven medical centers participated and contributed data from 455 women. The clinical pregnancy rate (number of pregnancies/total number of GIFT procedures) and the delivery rate (number of women who delivered at least one live baby/total number of GIFT procedures) were 35% and 32%, respectively. A statistically significant difference could not be found in the clinical pregnancy or delivery rates between those women who received propofol, nitrous oxide, midazolam, or isoflurane during GIFT and those who did not. CONCLUSIONS: No agent-related differences in pregnancy rates were found when propofol, nitrous oxide, isoflurane, or midazolam was used as part of the anesthetic technique for GIFT. Therefore, a more extensive prospective trial does not appear to be warranted.
Levy B, Mukherjee T, Hirschhorn K. Molecular cytogenetic analysis of uterine leiomyoma and leiomyosarcoma by comparative genomic hybridization. Cancer Genet Cytogenet 2000 Aug; 12(1): 1-8.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Mukherjee is not currently required to report Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Mount Sinai Health System (MSHS) physicians - including those employed by MSHS - do not always participate in the same health plans in which MSHS hospitals or facilities participate.
Information regarding insurance participation and billing by this physician may be found on this page or obtained by contacting this provider directly.
Insurance plans that the Mount Sinai Health System hospitals or facilities participate in can be found on the Mount Sinai Health System website.
635 Madison Avenue
New York, NY 10022
- Sunday 7:00am - 12:00pm
- Monday 7:00am - 6:00pm
- Tuesday 7:00am - 6:00pm
- Wednesday 7:00am - 6:00pm
- Thursday 7:00am - 6:00pm
- Friday 7:00am - 6:00pm
- Saturday 7:00am - 12:00pm
- Empire Plan for Government Employees
- Oxford Health Plans
- United Healthcare
- Master Card
- American Express
- Personal Check